SULFASALAZINE Side Effects

6382939-3 | Liver Function Test Abnormal, Neutropenia
on Sep 17, 2009 Female patient from UNITED KINGDOM , 57 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal, neutropenia. Sulfasalazine dosage: 500 Mg, 3x/day. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SYMBICORT (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

6373636-9 | Erythema, Malaise, Palpitations, Syncope, Tachyarrhythmia
Patient was taking Sulfasalazine (View Usage). Patient had the following side effects: erythema, malaise, palpitations, syncope, tachyarrhythmia on Sep 11, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 56 years of age, was diagnosed with psoriatic arthropathy and. Sulfasalazine dosage: 1 G, 2x/day.

6348690-0 | Acute Hepatic Failure, Bronchopulmonary Aspergillosis, Cardiac Arrest, Haemorrhage, Hepatitis Acute, Human Herpesvirus 6 Infection, Hypotension, Liver Transplant Rejection
Adverse event was reported on Aug 28, 2009 by a Female patient taking Sulfasalazine (View Usage) (Dosage: Unk) was diagnosed with polyarthritis and. Location: SWITZERLAND , 60 years of age, After Sulfasalazine was administered, patient had the following side effects: acute hepatic failure, bronchopulmonary aspergillosis, cardiac arrest (What is cardiac arrest?), haemorrhage, hepatitis acute, human herpesvirus 6 infection, hypotension, liver transplant rejection. During the same period patient was treated with VANCOMYCIN (Unk) (View Vancomycin Review and Vancomycin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6336717-1 | Back Pain, Musculoskeletal Pain, Pelvic Pain
on Aug 31, 2009 Female patient from UNITED STATES , 65 years of age, weighting 130.0 lb, was diagnosed with colitis ulcerative and was treated with Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), musculoskeletal pain, pelvic pain (What is pelvic pain?). Sulfasalazine dosage: 2 3 X Day Po. During the same period patient was treated with PREDNIZONE (View Prednizone Review and Prednizone Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ). Patient was hospitalized.


6333258-2 | Agranulocytosis, Appendicitis, Neutropenia
on Aug 17, 2009 Male patient from UNITED STATES , 50 years of age, was treated with Sulfasalazine (View Usage). Patient had the following side effects: agranulocytosis, appendicitis (What is appendicitis?), neutropenia. Sulfasalazine dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), CELECOXIB (View Celecoxib Review and Celecoxib Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.

6332824-8 | Cholangiolitis, Hepatitis, Myocarditis
Patient was taking Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: cholangiolitis, hepatitis (What is hepatitis?), myocarditis on Aug 24, 2009 from FRANCE Additional patient health information: Female patient , 29 years of age, . Sulfasalazine dosage: Unk. Patient was hospitalized.

6331469-3 | Alanine Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Influenza Like Illness
Adverse event was reported on Apr 29, 2009 by a Female patient taking Sulfasalazine (View Usage) (Dosage: 500 Mg) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 39 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood creatine phosphokinase increased, influenza like illness.

6315433-6 | Erectile Dysfunction
on Aug 07, 2009 Female patient from UNITED KINGDOM , 40 years of age, was diagnosed with psoriatic arthropathy, contusion and was treated with Sulfasalazine (View Usage). Patient had the following side effects: erectile dysfunction (What is erectile dysfunction?). Sulfasalazine dosage: 500 Mg, 2x/day. During the same period patient was treated with ACETAMINOPHEN W/ CODEINE (Unk) (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), DICLOFENAC (75 Mg, 3x/day) (View Diclofenac Review and Diclofenac Label ).

6310445-0 | Lip Blister, Odynophagia, Oropharyngeal Blistering, Rash Maculo-papular
on Aug 03, 2009 Female patient from UNITED KINGDOM , 51 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: lip blister, odynophagia, oropharyngeal blistering, rash maculo-papular. Sulfasalazine dosage: . Patient was hospitalized.

6301185-2 | Insomnia
Patient was taking Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: insomnia on Aug 06, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 180.0 lb, was diagnosed with colitis and. Sulfasalazine dosage: 2 Tabs 2xday Oral.

6290624-1 | Hallucination, Auditory, Nightmare
Adverse event was reported on Jul 28, 2009 by a Female patient taking Sulfasalazine (View Usage) (Dosage: 2 Bid Po) was diagnosed with arthritis (What is arthritis?) and. Location: UNITED STATES , 50 years of age, weighting 229.0 lb, Patient had the following side effects: hallucination, auditory, nightmare.

6288798-1 | Pancytopenia
on Jul 17, 2009 Female patient from SINGAPORE , 59 years of age, was treated with Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: pancytopenia. Sulfasalazine dosage: Frequency: Twice, Daily;. Patient was hospitalized.

6282538-8 | Bipolar I Disorder
on Jul 13, 2009 Female patient from TURKEY , 39 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: bipolar i disorder. Sulfasalazine dosage: 2 Grams, Daily. During the same period patient was treated with CHLOROQUINE (WATSON LABORATORIES) (250 Mg, Daily) (View Chloroquine (watson Laboratories) Review and Chloroquine (watson Laboratories) Label ). Patient was hospitalized.

6256389-4 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Arthralgia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Nausea
Patient was taking Sulfasalazine (View Usage). Patient had the following side effects: abdominal pain upper, alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, nausea (What is nausea?) on Jul 01, 2009 from UNITED STATES Additional patient health information: Male patient , 29 years of age, was diagnosed with colitis ulcerative and. Sulfasalazine dosage: 1500mg Bid Po. During the same period patient was treated with ROWASA (View Rowasa Review and Rowasa Label ), NEXIUM (View Nexium Review and Nexium Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), MIRALAX (View Miralax Review and Miralax Label ). Patient was hospitalized.

6253520-1 | Anxiety, Bipolar I Disorder, Delusion Of Grandeur, Delusional Disorder, Erotomanic Type, Hallucination, Auditory, Insomnia, Persecutory Delusion, Suicidal Ideation
Adverse event was reported on Jun 22, 2009 by a Female patient taking Sulfasalazine (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: TURKEY , 39 years of age, After Sulfasalazine was administered, patient had the following side effects: anxiety (What is anxiety?), bipolar i disorder, delusion of grandeur, delusional disorder, erotomanic type, hallucination, auditory, insomnia, persecutory delusion, suicidal ideation. During the same period patient was treated with CHLOROQUINE (View Chloroquine Review and Chloroquine Label ). Patient was hospitalized.

6251855-X | Lower Respiratory Tract Infection, Pancytopenia
on Jun 18, 2009 Female patient from UNITED KINGDOM , 77 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), cerebrovascular accident, peripheral vascular disorder and was treated with Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: lower respiratory tract infection, pancytopenia. Sulfasalazine dosage: 1 G, 2x/day. During the same period patient was treated with METHOTREXATE (Every Week) (View Methotrexate Review and Methotrexate Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FUROSEMIDE INTENSOL (View Furosemide Intensol Review and Furosemide Intensol Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6248142-2 | Visual Impairment
on Jun 24, 2009 Female patient from UNITED STATES , weighting 202.0 lb, was diagnosed with arthritis (What is arthritis?) and was treated with Sulfasalazine (View Usage). Patient had the following side effects: visual impairment. Sulfasalazine dosage: 500 Mg 2x Daily 047.

6238914-2 | Condition Aggravated, Psoriasis
Patient was taking Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: condition aggravated, psoriasis on Jun 10, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 51 years of age, was diagnosed with psoriatic arthropathy and. Sulfasalazine dosage: 2 G, 1x/day. During the same period patient was treated with ADCAL D3 (1 Df, 2x/day) (View Adcal-d3 Review and Adcal-d3 Label ), EVOREL (75 Ug, Unk) (View Evorel Review and Evorel Label ), PARACETAMOL (1 G, As Needed) (View Paracetamol Review and Paracetamol Label ).

6233610-X | Cushing's Syndrome, Hirsutism, Skin Striae, Swelling Face
Adverse event was reported on Jun 05, 2009 by a Female patient taking Sulfasalazine (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 19 years of age, Patient experienced the following unwanted or unexpected effects: cushing's syndrome, hirsutism, skin striae, swelling face. During the same period patient was treated with KENALOG (40 Mg, Unk) (View Kenalog Review and Kenalog Label ).

6233346-5 | Abnormal Behaviour, Affective Disorder, Anxiety, Bipolar Disorder, Hallucination, Auditory, Hallucination, Visual, Memory Impairment, Nervousness
on Jun 05, 2009 Female patient from TURKEY , 39 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Sulfasalazine (View Usage). Patient had the following side effects: abnormal behaviour, affective disorder, anxiety (What is anxiety?), bipolar disorder (What is bipolar disorder?), hallucination, auditory, hallucination, visual, memory impairment, nervousness. Sulfasalazine dosage: Unk. During the same period patient was treated with CHLOROQUINE (Unk) (View Chloroquine Review and Chloroquine Label ). Patient was hospitalized.

6217072-4 | Pancytopenia
on May 25, 2009 Female patient from JAPAN , 80 years of age, was treated with Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: pancytopenia. Sulfasalazine dosage: .

6210732-0 | Cushing's Syndrome, Hirsutism, Skin Striae, Swelling Face
Patient was taking Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: cushing's syndrome, hirsutism, skin striae, swelling face on May 20, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 19 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Sulfasalazine dosage: Unk. During the same period patient was treated with KENALOG (40 Mg, Unk) (View Kenalog Review and Kenalog Label ).

6210728-9 | Neutropenic Sepsis
Adverse event was reported on May 20, 2009 by a Female patient taking Sulfasalazine (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 36 years of age, Patient had the following side effects: neutropenic sepsis. Patient was hospitalized.

6207056-4 | Hepatic Failure
on May 18, 2009 Female patient from UNITED KINGDOM , 50 years of age, was treated with Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: hepatic failure. Sulfasalazine dosage: Unk. Patient was hospitalized.

6196305-7 | Diarrhoea, Hypotension, Pyrexia, Rash Maculo-papular
on May 08, 2009 Female patient from SINGAPORE , 54 years of age, was treated with Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, hypotension, pyrexia, rash maculo-papular. Sulfasalazine dosage: .

6195096-3 | Alanine Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Influenza Like Illness
Patient was taking Sulfasalazine (View Usage). Patient had the following side effects: alanine aminotransferase increased, blood creatine phosphokinase increased, influenza like illness on May 07, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 39 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Sulfasalazine dosage: 500 Mg, Unk.

6195090-2 | Cushing's Syndrome
Adverse event was reported on May 07, 2009 by a Female patient taking Sulfasalazine (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 19 years of age, After Sulfasalazine was administered, patient had the following side effects: cushing's syndrome. During the same period patient was treated with KENALOG (40 Mg, Unk) (View Kenalog Review and Kenalog Label ).

6192128-3 | Angle Closure Glaucoma
on May 04, 2009 Female patient from UNITED STATES , 60 years of age, was treated with Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: angle closure glaucoma. Sulfasalazine dosage: . During the same period patient was treated with AVALIDE (View Avalide Review and Avalide Label ), VIOXX (View Vioxx Review and Vioxx Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6190224-8 | Cushing's Syndrome
on Apr 30, 2009 Female patient from UNITED KINGDOM , 19 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Sulfasalazine (View Usage). Patient had the following side effects: cushing's syndrome. Sulfasalazine dosage: . During the same period patient was treated with KENALOG (40 Mg, Unk) (View Kenalog Review and Kenalog Label ).

6185946-9 | Alanine Aminotransferase Increased, Blood Creatine Phosphokinase Increased
Patient was taking Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: alanine aminotransferase increased, blood creatine phosphokinase increased on Apr 29, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 39 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Sulfasalazine dosage: 500 Mg.

6162036-2 | Alanine Aminotransferase Increased, Blood Bilirubin Increased, Encephalopathy, Hepatic Function Abnormal, International Normalised Ratio Increased, Liver Transplant, Liver Transplant Rejection
Adverse event was reported on Apr 06, 2009 by a Female patient taking Sulfasalazine (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 50 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood bilirubin increased, encephalopathy, hepatic function abnormal, international normalised ratio increased, liver transplant (What is liver transplant?), liver transplant rejection. Patient was hospitalized.

6157618-8 | Bone Marrow Toxicity, Cholangitis Sclerosing, Colitis Ulcerative, Disease Recurrence, Hepatic Failure, Hepatotoxicity, Pancytopenia, Treatment Noncompliance
on Apr 14, 2009 Male patient from UNITED STATES , 53 years of age, weighting 150.0 lb, was diagnosed with colitis ulcerative and was treated with Sulfasalazine (View Usage). Patient had the following side effects: bone marrow toxicity, cholangitis sclerosing, colitis ulcerative, disease recurrence, hepatic failure, hepatotoxicity, pancytopenia, treatment noncompliance. Sulfasalazine dosage: 2000 Milligram Bid Po.

6148625-X | Antineutrophil Cytoplasmic Antibody Increased, Glomerulonephritis, Renal Tubular Necrosis
on Mar 30, 2009 Female patient from JAPAN , 59 years of age, was diagnosed with colitis ulcerative and was treated with Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: antineutrophil cytoplasmic antibody increased, glomerulonephritis, renal tubular necrosis. Sulfasalazine dosage: Unk. Patient was hospitalized.

6129337-5 | Anorexia, Anuria, Diarrhoea, Dizziness, Headache, Impaired Work Ability, Malaise, Nausea
Patient was taking Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, anuria, diarrhoea, dizziness (What is dizziness?), headache (What is headache?), impaired work ability, malaise, nausea (What is nausea?) on Mar 23, 2009 from UNITED STATES Additional patient health information: Female patient , 26 years of age, weighting 181.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Sulfasalazine dosage: 6 Pills Per Day Po. Patient was hospitalized.

6056983-X | Chills, Headache, Heart Rate Increased, Hepatic Enzyme Increased, Hyponatraemia, Meningitis Viral, Myalgia, Nocturia, Pneumonia
Adverse event was reported on Jan 26, 2009 by a Female patient taking Sulfasalazine (View Usage) (Dosage: 500 Mg 2 Times A Day Po) was diagnosed with arthritis (What is arthritis?) and. Location: UNITED STATES , 64 years of age, weighting 142.0 lb, Patient had the following side effects: chills, headache (What is headache?), heart rate increased, hepatic enzyme increased, hyponatraemia, meningitis viral, myalgia, nocturia, pneumonia (What is pneumonia?). Patient was hospitalized and became disabled.

6056370-4 | Central Nervous System Lesion, Csf Test Abnormal, Encephalopathy, Status Epilepticus
on Jan 19, 2009 Female patient from TURKEY , 42 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: central nervous system lesion, csf test abnormal, encephalopathy, status epilepticus. Sulfasalazine dosage: 2 G, Daily. Patient was hospitalized.

5999476-8 | Ageusia, Anosmia
on Dec 05, 2008 Male patient from GERMANY , weighting 158.7 lb, was diagnosed with polyarthritis and was treated with Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, anosmia. Sulfasalazine dosage: 1000 Mg Daily, Oral. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), AGGRENOX (View Aggrenox Review and Aggrenox Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CALCIUM SANDOZ (CALCIUM, COLECALCIFEROL) (View Calcium Sandoz (calcium, Colecalciferol) Review and Calcium Sandoz (calcium, Colecalciferol) Label ), METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ).

5974802-4 | Hepatic Enzyme Increased, Human Herpesvirus 6 Infection, Lymphocyte Stimulation Test Positive
Patient was taking Sulfasalazine (View Usage). Patient had the following side effects: hepatic enzyme increased, human herpesvirus 6 infection, lymphocyte stimulation test positive on Nov 26, 2008 from JAPAN Additional patient health information: Male patient , 29 years of age, was diagnosed with colitis ulcerative and. Sulfasalazine dosage: Daily Dose:6gram. During the same period patient was treated with MESALAMINE (View Mesalamine Review and Mesalamine Label ). Patient was hospitalized.

5969138-1 | Gas Gangrene, Muscle Necrosis, Neutropenia
Adverse event was reported on Nov 20, 2008 by a Male patient taking Sulfasalazine (View Usage) (Dosage: Unk) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: AUSTRALIA , 26 years of age, After Sulfasalazine was administered, patient had the following side effects: gas gangrene, muscle necrosis, neutropenia. Patient was hospitalized.

5964427-9 | Autoimmune Hepatitis, Interstitial Lung Disease, Platelet Count Decreased, Scleroderma
on Nov 19, 2008 Female patient from JAPAN , 66 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: autoimmune hepatitis, interstitial lung disease, platelet count decreased, scleroderma (What is scleroderma?). Sulfasalazine dosage: . Patient was hospitalized.

5964342-0 | Polyneuropathy
on Nov 12, 2008 Female patient from NETHERLANDS , 21 years of age, was diagnosed with pain (What is pain?), joint destruction and was treated with Sulfasalazine (View Usage). Patient had the following side effects: polyneuropathy. Sulfasalazine dosage: .

5957204-6 | Glomerulonephritis Rapidly Progressive, Renal Impairment
Patient was taking Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: glomerulonephritis rapidly progressive, renal impairment on Nov 06, 2008 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Sulfasalazine dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), D PENICILLAMINE (View D-penicillamine Review and D-penicillamine Label ). Patient was hospitalized.

5955855-6 | Lower Respiratory Tract Infection, Pancytopenia
Adverse event was reported on Nov 07, 2008 by a Male patient taking Sulfasalazine (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), cerebrovascular accident, peripheral vascular disorder and. Location: UNITED KINGDOM , 77 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: lower respiratory tract infection, pancytopenia. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), DIPYRIDAMOLE (Daily Dose:200mg) (View Dipyridamole Review and Dipyridamole Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

5954010-3 | Abscess Oral, Cellulitis, Mouth Ulceration, Neutropenic Sepsis
on Nov 06, 2008 Male patient from UNITED KINGDOM , 42 years of age, weighting 154.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), psoriatic arthropathy, hypothyroidism, abscess (What is abscess?), oropharyngeal pain and was treated with Sulfasalazine (View Usage). Patient had the following side effects: abscess oral, cellulitis (What is cellulitis?), mouth ulceration, neutropenic sepsis. Sulfasalazine dosage: . During the same period patient was treated with ETORICOXIB (View Etoricoxib Review and Etoricoxib Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METRONIDAZOLE (Daily Dose:400mg) (View Metronidazole Review and Metronidazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PENICILLIN V (Daily Dose:500mg) (View Penicillin V Review and Penicillin V Label ). Patient was hospitalized.

5947382-7 | Pleural Effusion
on Oct 29, 2008 Female patient from JAPAN , 43 years of age, was diagnosed with arthralgia and was treated with Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: pleural effusion. Sulfasalazine dosage: .

5942552-6 | Toxic Epidermal Necrolysis
Patient was taking Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis on Oct 27, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 69 years of age, was diagnosed with systemic lupus erythematosus and. Sulfasalazine dosage: .

5939721-8 | Abdominal Discomfort, Abdominal Pain Upper, Anorexia, Fluid Intake Reduced, Headache, Hypophagia, Nausea, Pain In Extremity
Adverse event was reported on Oct 31, 2008 by a Female patient taking Sulfasalazine (View Usage) (Dosage: Two Tablets Bid Po) was diagnosed with arthritis (What is arthritis?) and. Location: UNITED STATES , weighting 164.0 lb, Patient had the following side effects: abdominal discomfort, abdominal pain upper, anorexia, fluid intake reduced, headache (What is headache?), hypophagia, nausea (What is nausea?), pain in extremity. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ).

5908147-5 | Agranulocytosis
on Sep 25, 2008 Male patient from JAPAN , 72 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Sulfasalazine (View Usage). After Sulfasalazine was administered, patient had the following side effects: agranulocytosis. Sulfasalazine dosage: Daily Dose:500mg. During the same period patient was treated with PREDNISOLONE (Daily Dose:5mg) (View Prednisolone Review and Prednisolone Label ).

5903187-4 | Hepatic Failure, Hepatitis Acute
on Sep 29, 2008 Female patient from UNITED STATES , 37 years of age, was diagnosed with skin disorder and was treated with Sulfasalazine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure, hepatitis acute. Sulfasalazine dosage: . Patient was hospitalized.

5890230-4 | Conjunctivitis
Patient was taking Sulfasalazine (View Usage). Patient had the following side effects: conjunctivitis on Sep 09, 2008 from JAPAN Additional patient health information: Female patient , 54 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Sulfasalazine dosage: Daily Dose:1gram. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.